| abstract |
(57) [Problem] To provide a therapeutic agent useful for treatment of intraocular neovascular diseases, particularly retinopathy of prematurity and suitable for local administration. SOLUTION: A therapeutic agent for an intraocular neovascular disease which contains a VEGF / VPF antagonist as an active ingredient. VEGF / VP The F antagonist is preferably an antibody to VEGF / VPF and is preferably administered intravitreally. |